أخبار السوق اليوم — عناوين الأسهم والعملات الرقمية المنتقاة بالذكاء الاصطناعي

Novo Nordisk's CEO discusses the demand for its weight-loss pill Wegovy, with over 246,000 users, and addresses concerns over supply, pricing, and a lawsuit against Hims for alleged copycats.

Hims & Hers Health stock dropped 16% after facing a lawsuit from Novo Nordisk and FDA scrutiny, impacting investor sentiment.

Novo Nordisk is suing Hims & Hers Health Inc.

Bondholders have filed a lawsuit against the owners of the American Dream mall and a New Jersey town, alleging collusion to reduce the assessed value of the mall, which jeopardizes repayment of $800 million in municipal debt.

Ethiopia is facing a potential lawsuit from bondholders over a $1 billion debt default, as private-sector lenders claim official creditors have blocked a deal to restructure the debt.

Music publishers have escalated their lawsuit against Anthropic, accusing the company of 'flagrant piracy' of 20,000 copyrighted works, up from the initial 500 works, and are seeking $3 billion in damages.

Cere Network is facing a $100M lawsuit over alleged token sales fraud, adding to the company's legal woes this month.

Telesat Canada is facing a lawsuit from its creditors, who claim the company engaged in 'fraudulent' asset transfers that breached lending terms, potentially affecting its financial stability and future operations.

A federal judge in Washington DC has lifted the stop-work order on Ørsted's Revolution Wind offshore project, allowing the company to resume construction after a national security-related suspension.

Automattic has filed counterclaims against WP Engine, alleging trademark misuse and misleading users, in a WordPress lawsuit.

Rivian has agreed to pay $250M to settle a lawsuit over a 2022 price hike on its R1 lineup, which negatively impacted its stock price.

Tether (USDT) faces a lawsuit alleging $42 million in USDT was frozen due to its connection to a pig butchering scam, while Australian crypto firms risk significant fines for failing to meet licensing deadlines.